Harpoon Therapeutics harpoontx.com


Public list: Pharma Startups (4732) Cancer Therapeutics (1137)

Harpoon Therapeutics is an immuno-oncology company focused on the discovery and development of T-cell engaging biologics for the treatment of cancer and other diseases. Harpoon Therapeutics created an antibody-based drug discovery platform called TriTAC (tri-specific T-cell activating construct) to unleash the targeted cell-killing properties of a patient's own immune system through T-cell activation. This approach has been created to penetrate tissues and extend serum exposure and has the poten...Show all

Harpoon Therapeutics is an immuno-oncology company focused on the discovery and development of T-cell engaging biologics for the treatment of cancer and other diseases. Harpoon Therapeutics created an antibody-based drug discovery platform called Tri...Show all

Company (Alive / Active)

Phone: 650-443-7400

Fax:

4000 Shoreline Ct
#250
South San Francisco, 94080
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Harpoon Therapeutics $115M Nov 12, 2018
Neon Therapeutics $261M Jun 27, 2018
BeneVir Biopharm $10M May 2, 2018
See all 12 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Harpoon Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 10 investors

Competitors

Company Status Description Investors
See all 12 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Single domain serum albumin binding protein Sep 14, 2017 Mar 20, 2018 Patent
Trispecific binding proteins and methods of use May 20, 2016 Jul 18, 2017 Patent
Single chain variable fragment cd3 binding proteins Sep 14, 2017 Application
Trispecific binding proteins and methods of use Jun 22, 2017 Application
Single chain variable fragment cd3 binding proteins May 19, 2017 Application
See all 6 patents